China
has fined UK pharmaceuticals firm GlaxoSmithKline $490m (£297m) after a court
found it guilty of bribery.
The
record penalty follows allegations the drug giant paid out bribes to doctors
and hospitals in order to have their products promoted.
The
court gave GSK's former head of Chinese operations, Mark Reilly, a suspended
three-year prison sentence and he is set to be deported.
Other
GSK executives have also been given suspended jail sentences.
The
guilty verdict was delivered after a one-day trial at a court in Changsha,
according to the Xinhua news agency.
Chinese
authorities first announced they were investigating GSK in July last year, in
what has become the
